Minerva Neurosciences NERV
NASDAQ NERV
$4.43 -0.26 (-5.54%)
At close: Sep 4, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Prepaid Assets (2013 - 2026)

Minerva Neurosciences' (NERV) quarterly Prepaid Assets came in at $941883.0 in Q1 2026, up 76.12% YoY from $534798.0 in Q1 2025, and up 35.0% on a QoQ basis from $697676.0 in Q4 2025.

Analysis

Minerva Neurosciences (NERV) Prepaid Assets (2013 - 2026) Analysis & Trends

Minerva Neurosciences (NERV) has 14 years of Prepaid Assets data on file, last reported at $941883.0 in Q1 2026.

  • Quarterly Prepaid Assets rose 76.12% year-over-year to $941883.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $941883.0 (up 76.12% YoY) and the FY2025 annual result came in at $697676.0, down 13.54% from the prior year.
  • Prepaid Assets climbed to $941883.0 in Q1 2026, from $697676.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $1.4 million in Q3 2022 to a low of $184821.0 in Q2 2022.
  • A 5-year average of $733855.5 and a median of $697676.0 in 2025 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2022 — Prepaid Assets sank 79.7% — and 2023, when it jumped 78.09%.
  • Tracing NERV's Prepaid Assets over 5 years: stood at $848117.0 in 2022, then increased by 16.71% to $989865.0 in 2023, then dropped by 18.48% to $806895.0 in 2024, then retreated by 13.54% to $697676.0 in 2025, then jumped by 35.0% to $941883.0 in 2026.
  • The last three Prepaid Assets figures came in at $941883.0 (Q1 2026), $697676.0 (Q4 2025), and $633533.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Minerva Neurosciences 207.37 Mn 207.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.37 Mn
Mar 31, 2026 941,883.00
Dec 31, 2025 697,676.00
Sep 30, 2025 633,533.00
Jun 30, 2025 199,615.00
Mar 31, 2025 534,798.00
Dec 31, 2024 806,895.00
Sep 30, 2024 1.31 Mn
Jun 30, 2024 428,018.00
Mar 31, 2024 702,546.00
Dec 31, 2023 989,865.00
Sep 30, 2023 1.22 Mn
Jun 30, 2023 329,153.00
Mar 31, 2023 596,045.00
Dec 31, 2022 848,117.00
Sep 30, 2022 1.40 Mn
Jun 30, 2022 184,821.00
Mar 31, 2022 650,481.00
Dec 31, 2021 1.35 Mn
Sep 30, 2021 1.75 Mn